Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2017-08-01 | 2018-05-11 | 17844 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2019-09-26 | 2019-10-04 | 94825 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-01-28 | 2021-04-08 | 132672 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-05-06 | 2021-06-10 | 138904 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-06-24 | 2021-07-15 | 141463 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-08-27 | 2021-09-23 | 144726 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-09-16 | 2022-04-21 | 145780 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2022-06-09 | 2022-06-17 | 162283 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2022-12-01 | 2022-12-15 | 176776 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2024-09-05 | 2024-09-19 | 236802 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2024-12-13 | 2025-03-13 | 245601 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2025-01-16 | 2025-02-13 | 247885 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2025-03-06 | 2025-04-24 | 252075 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2025-03-27 | 2025-04-10 | 253568 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2025-05-08 | 2025-10-02 | 256917 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Actual shortage | 2025-10-23 | 2025-11-27 | 270218 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Actual shortage | 2025-10-30 | 2025-11-27 | 270660 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2021-10-21 | 2021-12-17 | 147699 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2022-08-18 | 2022-12-22 | 167237 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2023-06-08 | 2023-07-05 | 194180 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-OLMESARTAN | 40MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117500 |
| TEVA-OLMESARTAN / HCTZ | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| TEVA-OLMESARTAN / HCTZ | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| TEVA-OLMESARTAN / HCTZ | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256082 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258417 |
| ACT QUETIAPINE | 300MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258643 |
| ACT QUETIAPINE | 200MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258648 |
| ACT RANITIDINE | 150MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115079 |
| ACT RANITIDINE | 300MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115082 |
| ACT RIZATRIPTAN | 10MG | TABLET | Discontinued | 2021-07-22 | 2021-07-22 | 142912 |
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65292 |
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |